5-HT₆ Receptor

5-HT₆ receptor is a serotonin receptor family member with almost exclusive CNS expression, abundant in limbic and cortical regions^[1]. Mechanistically, 5-HT₆ receptor research links the target to regulation of glutamatergic and cholinergic neuronal activity, with reported roles in cognition, feeding, affective state, and seizures^[1]. Its pharmacology remains important because antagonists modulate learning, memory, and food intake, while agonist pharmacology remains under evaluation^[2]. In cognitive disease models, 5-HT₆ receptor antagonists show preclinical efficacy across episodic memory, social cognition, executive function, and working memory, partly through decreased GABA release, disinhibition of glutamate or acetylcholine release, and enhanced synaptic plasticity^[3]. In Alzheimer’s disease studies, RVT-101/intepirdine was evaluated as an adjunct to donepezil in mild-to-moderate disease, with responder analyses and activities-of-daily-living endpoints reported^[4]. Compared with related serotonin receptor isoforms such as 5-HT_4(a) and 5-HT_4(b), where ligand-induced internalization is isoform-specific, 5-HT₆ literature emphasizes CNS distribution, neurotransmitter modulation, and ligand discovery rather than splice-isoform trafficking^[5][1]. For experimental applications, selective 5-HT₆ receptor antagonists, including 2-aminoimidazole, azaindole, and tetrahydropyridoindole chemotypes, provide tools for studying receptor selectivity, cognition, satiety, and in vivo pharmacology^[6][7][8].